VEGF receptor 2 inhibitor nintedanib completely reverts VEGF-A165-induced disturbances of barriers formed by retinal endothelial cells or long-term cultivated ARPE-19 cells
Heidrun L. Deissler*, Jan Niklas Stutzer, Gerhard K. Lang, Salvatore Grisanti, Gabriele E. Lang, Mahdy Ranjbar
*Korrespondierende/r Autor/-in für diese Arbeit
28
Link öffnet neuen Tab
Zitate (Scopus)